Article Details

NRx Aims to Bring Zyesami to Market Based on Real-World Data in Treating Seriously Ill ... - BioBuzz

Retrieved on: 2022-02-15 02:09:11

Tags for this article:

Click the tags to see associated articles and topics

NRx Aims to Bring Zyesami to Market Based on Real-World Data in Treating Seriously Ill ... - BioBuzz. View article details on HISWAI: https://biobuzz.io/nrx-aims-to-bring-zyesami-to-market-based-on-real-world-data-in-treating-seriously-ill-covid-19-patients/

Excerpt

NRx's Zyesami can potentially help save patients who are seriously ill and have failed to respond to Gilead Sciences' Remdesivir.

Article found on: biobuzz.io

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up